Pancreatic Cancer Research

ResearcherUniversity of North Carolina at CharlotteNo recent work listed

Shu-ta Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3351-277X; OpenAlex author ID A5062378220. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: 1 paper

Papers 4

  1. Tumor -Associated MUC1 Regulates TGF-β Signaling and Function in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/2020.04.29.068577↗
  2. Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cells8091070↗
  3. Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles. Co-author DOI 10.1186/s12885-018-4393-7↗
  4. Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004. Co-author DOI 10.1371/journal.pone.0193260↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pinku Mukherjee · 4 shared papers, 2018–2020 · strength 0.37
  2. Priyanka Grover · 3 shared papers, 2018–2020 · strength 0.30
  3. Mahboubeh Yazdanifar · 3 shared papers, 2018–2020 · strength 0.27
  4. Ru Zhou · 3 shared papers, 2018–2020 · strength 0.27
  5. Mukulika Bose · 2 shared papers, 2019–2020 · strength 0.19
  6. Sritama Nath · 1 shared paper, 2020 · strength 0.10
  7. John F. Maher · 1 shared paper, 2019 · strength 0.09
  8. Didier Dréau · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.